Gastrointestinal Diseases from Animals

In a lengthy interview published on The Cut this week , writer/comedian/provocateur Lena Dunham spoke about her struggles with physical pain from both a connective-tissue disease and fibromyalgia, telling writer Allison P. Davis that she wants to be “the face” of the latter. As a young writer who also has fibromyalgia—although I am not as advanced in my career or as well connected as Dunham is—let me take you through why this is a bad idea. There are approximately 10 million people in the United States with fibromyalgia ; the condition is lifelong, and tends to be characterized by widespread soft tissue/muscle pain, chronic fatigue, bowel problems, and other symptoms that can vary from person to person. Fibromyalgia has also been the subject of considerable controversy within the medical field and in the public eye. There are plenty of people who do not “believe” that it exists, or that people with it are really suffering from some sort of psychological or conversion disorder instea

A baby is one of just five people in the UK to suffer from a condition that caused him to be born with back-to-front legs and no buttocks. Tracy Fletcher gave birth to Baron last month. He has caudal regression syndrome (CDS), which  has also left him with clubbed feet and no control over his lower body. Ms Fletcher, 39, from Cheltenham, was advised to abort her pregnancy after the rare condition was picked up at a 20-week scan.  Despite being warned Baron would never walk, as well as suffer severe kidney, bowel and bladder problems, Ms Fletcher continued with the pregnancy. 'We've accepted that if he's disabled we'll help as much we can. We don't want him brought up any differently to any other baby,' Ms Fletcher said. Baron was born last month with his legs back to front due to a rare condition that affects just five people in the UK. Although his parents Tracey Fletcher and Edward were aware of what was coming, she described his legs as being '

TEL-AVIV, Israel and RALEIGH, N.C., Nov. 29, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily focused on proprietary drugs for gastrointestinal diseases, today announced that Mr. Dror Ben-Asher, chief executive officer of RedHill, will present a corporate overview at the BMO 2018 Prescriptions for Success Healthcare Conference on Wednesday, December 12, 2018, at 3:00 p.m. EST  at the Mandarin Oriental Hotel, New York. The presentation will be broadcast live and available via replay for 30 days on the Company's website,  http://ir.redhillbio.com/events . Please access the website at least 15 minutes ahead of the conference call to register. About RedHill Biopharma Ltd.       RedHill Biopharma Ltd. (Nasdaq: RDHL) (Tel-Aviv Stock Exchange: RDHL) is a specialty biopharmaceutical company, primarily focused on the development and commercialization of late clin

-The First Polyethylene Glycol Preparation for Chronic Constipation in Japan- TOKYO, Nov 29, 2018 - (JCN Newswire) - EA Pharma Co., Ltd., EA Pharma's parent company Eisai Co., Ltd. and Mochida Pharmaceutical Co., Ltd. announced today that the constipation treatment "MOVICOL" (Development code AJG555) was included in Japan's National Health Insurance drug price list as of November 20, 2018, and EA Pharma and Mochida launched the product onto the Japan market today. MOVICOL is the first polyethylene glycol preparation indicated for treatment of chronic constipation(1) in Japan, available for adults and children 2 years of age and older. MOVICOL increases the moisture in the intestinal tract by osmolality of its main ingredient polyethylene glycol (macrogol 4000), which increases fecal moisture, softens feces, increases fecal volume and physiologically activates the peristaltic movement of the colon to promote bowel movement. Furthermore, MOVICOL is a po

Written by Eric Oliver | November 28, 2018 | Print  | Email CMS released a procedure price lookup tool to provide consumers a view of what common procedures cost in ASCs and hospital outpatient departments. The tool shows how much a patient pays both with Medicare and without a supplement (Medigap) policy. Here's the average total cost for 10 common gastroenterology procedures: 1. Colonoscopy, flexible; with biopsy, single or multiple (45380) ASC: $488 HOPD: $936 2. Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) by snare technique (45385) ASC: $488 HOPD: $936 3. Colonoscopy, flexible; diagnostic, including collection of specimen(s) by brushing or washing, when performed (separate procedure) (45378) ASC: $370 HOPD: $710 3. Cancer screening of the colon (large bowel) using an endoscope (colonoscopy) for high-risk individuals (G0105) ASC: $370 HOPD: $710 4. Colonoscopy, flexible; with endoscopic mucosal resection (45390) ASC: $488 H

Xeljanz — a small-molecule Janus kinase inhibitor — appeared safe for the treatment of patients with moderate-to-severe ulcerative colitis, based on more than four years of data from global clinical trials published in Clinical Gastroenterology and Hepatology . William J. Sandborn, MD, of the division of gastroenterology at the University of California San Diego, and colleagues wrote that the drug’s (tofacitinib, Pfizer) safety profile in UC generally mirrored that of anti-TNF therapies and with tofacitinib for rheumatoid arthritis except for higher rates of herpes zoster. “Increased rates of [herpes zoster] have previously been observed with tofacitinib in other disease populations. In the UC maintenance cohort, a dose relationship in the risk of [herpes zoster] was demonstrated,” they wrote. “Most [herpes zoster] events were limited to cutaneous involvement over one or two adjacent dermatomes and did not require permanent discontinuation.” To explore the drug’s safety profile ,

More people worldwide are vulnerable to the health impacts of climate change than ever before, according to a major new report involving researchers at the University of York. Advertisement The report has found that there has been a lack of progress in reducing fossil fuel emissions. The Lancet Countdown Report tracks climate change and health over time and monitors commitments made by governments under the Paris Climate Agreement. The 2018 report notes that: 157 million more people were exposed to heatwave events in 2017 compared with 2000 18 million more people were exposed to heatwave events in 2017 compared to 2016 The average person experiences an additional 1.4 days of heatwaves per year in 2017 compared with 2000 153 billion hours of labor were lost in 2017 due to heat, an increase of more than 62 billion hours (3.2 billion weeks of work) since 2000 Between 2010 and 2016, air pollution concentrations worsened in 70% of cities worldwide In 2017, a total of 712 extr

Competition in commercial health insurance markets is shrinking for half the country. That's the word from the American Medical Association's "Competition in Health Insurance: A Comprehensive Study of US Markets" report. The findings showed half of all states had commercial health insurance markets that were less competitive in 2017 than in 2016. Advertisement The report offers a detailed picture of competition in health insurance markets for all 50 states and the District of Columbia, as well as 380 metropolitan statistical areas, or MSAs, based on 2017 data captured from commercial enrollment in fully and self-insured health maintenance organizations, preferred provider organizations and point-of-service plans, consumer-driven health plans and public health exchanges. THE IMPACT The study aims to help policymakers and regulators focus in on markets where mergers may negatively impact both patients and providers, as well as to identify markets where closer mon

[unable to retrieve full-text content] Findings Challenge Recommended Time Frame for Barrett's Eradication    Gastroenterology & Endoscopy News For patients with Barrett's esophagus that is indicated for endoscopic eradication, complete eradication of intestinal metaplasia (CEIM) within 18 months has ... https://ift.tt/2TYTaMz

In an online survey developed by the Society for Women's Health Research, a majority of school nurses reported that the pre-K-12 schools they work for do not have written policies on student bathroom use and do not have education for students and teachers on bladder health. The survey, created by SWHR's Interdisciplinary Network on Urological Health in Women and distributed by the National Association of School Nurses, garnered responses from 362 school nurses, covering pre-K/elementary, middle, and high schools across rural, suburban, and urban areas. Less than 8% of nurses reported that their schools have a written policy on student bathroom use (64% reported no policy, 28% were unsure). Nearly half said students have free bathroom access, with permission required only as a formality, while others reported varying timed and supervised bathroom breaks. School nurses reported the following as the top reasons teachers give for restricting bathroom access for students durin

The results of a new pair of studies from investigators in the United States and Canada have debunked a previously accepted idea that probiotic supplements are helpful to children with gastroenteritis. Gastroenteritis leads to 1.7 million pediatric emergency room visits and more than 70,000 hospitalizations in the United States each year. Treatment for these infections typically includes replacing lost fluids and electrolytes; however, previous research has indicated that treatment for healthy infants and children can include supplementation with probiotics , to reduce the severity and duration of symptoms by restoring normal bacterial microflora in the gastrointestinal tract. Now, investigators on the pair of studies, published in the New England Journal of Medicine , found that probiotic supplements were ineffective at reducing diarrhea and vomiting in children with gastroenteritis. In the US study, investigators looked at 971 children aged 3 months to 4 years who were treated for

SINGAPORE - In yet another case of food poisoning, 131 people have fallen ill after consuming food from a caterer. The victims included Kindergarten 2 children and teachers who were attending a learning camp. In a joint statement, the National Environmental Agency (NEA), Ministry of Health (MOH) and Agri-Food and Veterinary Authority (AVA) said that they were investigating an outbreak of gastroenteritis traced to the consumption of food prepared by FoodTalks Caterer & Manufacturer, located at Shimei East Kitchen in Bedok, on Monday (Nov 26). As of Tuesday, 131 cases of gastroenteritis have been reported. None of the victims have been hospitalised. The MOH, NEA and AVA conducted a joint inspection of the caterer's premises on Tuesday. As part of the investigations, food handlers were sent for stool screening, and food and environmental samples were taken for testing, the agencies said. According to Chinese daily Lianhe Zaobao, the food poisoning victims had attended a

Hong Kong has suspended the sale and import of romaine lettuce – also known as cos – harvested in California, after US food safety investigators found the vegetable harvested in the state appeared to be the source of the recent E coli outbreak in North America. In a statement on Tuesday, Hong Kong’s Centre for Food Safety said the import and sale of romaine lettuce harvested in California “has been suspended with immediate effect”. The centre also urged the trade to stop using and selling romaine lettuce harvested in California immediately and asked the public not to eat such lettuce from California or unknown sources. A centre spokesman said: “The [centre] has been closely following up on the US romaine lettuce incident and has earlier held all romaine lettuce from the US and Canada for testing at the import level. Gene mapping used by US scientists to combat food poisoning “According to the latest information provided by the US Food and Drug Administration (FDA) upon investiga

The 59th national conference of the Indian Society of Gastroenterology, ISGCON-2018, will begin here on Wednesday. Mathew Philip, organising secretary, said the meet would take stock of the gastrointestinal disease burden in the country, effective strategies to tackle them and focus on latest updates and advances in the field of gastroenterology, hepatology and gastrointestinal endoscopy. The four-day conference will be inuaugurated by Cochin International Airport Limited Managing Director V.J. Kurian at the Lulu Bolgatty International Convention Centre. The conference is being organised by the Kerala chapter of Indian Society of Gastroenterology (ISG) in association with the Cochin Gut Club. Over 2,500 delegates from across the country and more than a hundred eminent specialist doctors from the United States, and Europe, Asian and African countries will hold deliberations to share their treatment strategies, expertise and cutting edge techniques in gastroenterology. The specialise

Pune, India, 27 th November 2018: MarketResearchFuture announced addition of new report, titled “Capsule Endoscopy Market Research Report- Forecast to 2023”. Market Research Future (MRFR) has published a research report that foretells expansion of the global capsule endoscopy market with 8.7% CAGR (Compound Annual Growth Rate) between 2018 and 2023. The key factors that are driving the growth of this market during the forecast period include demand for fast and accurate diagnostic tools, growing geriatric population, and rising occurrences of gastrointestinal diseases. However, the high cost of capsule endoscopy, limited reimbursement, and the risk of capsule retention may hamper the growth of this market. GET SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/1359 The global capsule endoscopy market has been segmented on the basis of application, end user, purpose, type, and region. On the basis of application, the market has been segmented into Crohn’s disease

ROCKVILLE, Md., Nov. 27, 2018 /PRNewswire/ -- HighTide Therapeutics Inc., a clinical-stage biopharmaceutical company, announced that the U.S. FDA has granted Fast Track Designation to its investigational new drug, HTD1801, for the treatment of patients with nonalcoholic steatohepatitis (NASH). Liping Liu, PhD, Chief Executive Officer of HighTide, commented, "NASH represents a rapidly developing field with potential therapeutic options in the pipeline, yet none have made it to the market. At the recent AASLD Liver Meeting, experts in the field generally agreed that modest clinical responses to date are likely to be improved by thoughtful combination approaches. HTD1801, a multifunctional oral therapeutic, was designed to address the complex nature of NASH, especially for patients with comorbid diabetes and/or dyslipidemia. We are pleased by the FDA's decision and look forward to bringing this much needed solution to millions of patients suffering from this disease."

Written by Rachel Popa | November 27, 2018 | Print  | Email Here are 24 benchmarks to know on gastroenterology procedures in ASCs, gastroenterologist salary and more from a collection of sources in the industry. Surgery centers with more than two specialties accounted for 30 percent of ASCs billing Medicare in 2016, and single-specialty gastroenterology centers accounted for 22 percent, according to The Medicare Payment Advisory Commission's March 2018 report to Congress. The report defines a "single-specialty ASC" as one with more than 67 percent of its Medicare claims in one clinical specialty and a "multispecialty ASC" as one with more than 67 percent of its Medicare claims in more than one clinical specialty. The sum of multispecialty percentages doesn't equal 100 the total due to rounding. Here's a breakdown on the specializations that billed Medicare in 2016. Gastroenterology 1. Number of ASCs: 1,025 2. Share of all ASCs: 22 percent Gast

PHILADELPHIA — In this exclusive video from the American College of Gastroenterology Annual Meeting, William Chey, MD, FACG, of the division of gastroenterology at the University of Michigan Health System, discusses a survey he conducted along with Shire Pharmaceuticals that explored the burden of illness related to chronic constipation . The survey comprised more than 800 patients with chronic constipation, as well as more than 200 gastroenterologists from across the United States. “It allowed not only a comprehensive deep dive into patients’ illness experience and what doctors think about constipation, but a comparison of the results yield from the patients as well as the gastroenterologists,” Chey told Healio Gastroenterology and Liver Disease . One of the main highlights of the survey, according to Chey, was that more than half of the patients reported that they spent more than an hour a day on the toilet, whereas 10% spent more than 5 hours. Although doctors seemed to apprecia

Gastroenterology Lavage Kits Market 2018 – 2025 This comprehensive Gastroenterology Lavage Kits Market research report includes a brief on these trends, size, share that can help the businesses operating in the industry to understand the market and strategize for their business expansion accordingly. The research report analyses the market size, industry share, growth, key segments, CAGR, Application and key drivers. Request For Sample Copy of Report – https://www.marketsresearch.biz/report/global-gastroenterology-lavage-kits-market-192423#request-sample The report organizes the Gastroenterology Lavage Kits Market across the globe into distinct portion based on industry standards. It also distinguishes the market based on geographical regions. The Gastroenterology Lavage Kits report mainly throws light on dominant players in the regions of (North America, Europe, China, Japan, Latin America and India). Other regions can be added accordingly. Gastroenterology Lavage Kits Market r

Advertisement Using a screening colonoscopy database of 13,618 asymptomatic subjects, 30–49 years old, and 17,999 subjects, 50–75 years old, a cross-sectional study was performed to examine the prevalence of sessile serrated polyps (SSPs) and the relationship between SSP risk and modifiable lifestyle factors in asymptomatic young adults. In an analysis of a colonoscopy screening database, they found that smoking and alcohol consumption were related to any SSPs and large SSPs in asymptomatic young adults. Five years of cessation of smoking reduced the risk of SSPs and large SSPs. For the primary prevention of SSPs in young adults, early lifestyle changes might, therefore, be suggested. Read the full article on Clinical Gastroenterology and Hepatology https://ift.tt/2E3bwHc

Vitamin and mineral supplements may be beneficial for people who aren’t getting the micronutrients they need through their diet, but do not help in preventing chronic disease, according to an updated position paper published by the Academy of Nutrition and Dietetics. Advertisement “The dietary intakes of many Americans are inadequate in some micronutrients, so micronutrient supplements can be used to help individuals meet a nutrient requirement or to treat a diagnosed deficiency,” according to the authors. “There was insufficient evidence to determine whether taking multivitamin mineral supplements was beneficial for preventing chronic disease in generally healthy people.” The academy’s updated position paper “Micronutrient Supplementation” was published in the November issue of the Journal of the Academy of Nutrition and Dietetics : It is the position of the Academy of Nutrition and Dietetics that micronutrient supplements are warranted when requirements are not being met throu

PHILADELPHIA — In this exclusive video from the American College of Gastroenterology Annual Meeting, Mike Nedham, product strategy lead for GI at Shire, discusses a survey the company conducted that he said revealed a need for more treatments for chronic idiopathic constipation . “More than 70% of the patients who were interviewed said that [chronic idiopathic constipation] has, still, a really significant impact on their overall quality of life on a daily basis,” Nedham told Healio Gastroenterology and Liver Disease . “Many of the patients commented that despite the OTC and prescription therapies that they had available, they were still having a lot of problems with their symptoms.” Nedham said some patients even reported that they would rather deal with the symptoms than the adverse effects of the treatments they were using. The survey also included responses from gastroenterologists from across the United States. “More than 80% of them said, actually, they would really like to

Children with stomach viruses increasingly are given probiotics to ease symptoms of vomiting and diarrhea. But a major U.S. study led by Washington University School of Medicine in St. Louis shows that a commonly used probiotic is not effective in improving symptoms in young patients with gastroenteritis. The findings are published Nov. 22 in The New England Journal of Medicine. While rarely fatal in the United States, gastroenteritis — frequently yet erroneously called “stomach flu” — accounts for 1.7 million pediatric emergency room visits and more than 70,000 hospitalizations each year. The study, involving nearly 1,000 children ages 3 months to 4 years, provides evidence against the popular and costly use of probiotics — live microorganisms believed to restore the balance of intestinal bacteria and boost the immune system. “Probiotics have become an increasingly popular way to treat children experiencing acute gastroenteritis,” said the study’s lead author, David Schnadower, M